Moreover, it has been verified that LOXL1-AS1 sponges miR-377–3p, the other direct target of LoxL1-AS1, and miR-377–3p acts as an upstream direct regulator of nuclear factor I B (NFIB) gene in liver cancer (82). This evidence concerns the gene NFIB and liver cancer.